Diagnostic Lessons Learned From the COVID-19 Pandemic Beyond SARS-CoV-2

Among the dramatic effects of the COVID-19 pandemic are the profound changes affecting the field of clinical diagnostics. At the onset of the pandemic, access to—and questions about—testing were among the most vexing challenges facing patients and providers. As a result, hundreds of SARS-CoV-2 assays have been brought to market over the past 3 years, most in the United States under an emergency use authorization (EUA) from the FDA.¹ Even now, as the